Screening protocol for TAVR- candidates
All patients being admitted with aortic valve disease or failed
bioprosthesis are discussed in a multidisciplinary “heart valve
board”, consisting of cardiac surgeons, cardiac anesthesiologists and
cardiologists. For risk estimation, the Society of Thoracic Surgeons
(STS)-Score and the EuroSCORE were used. Subsequently, patients were
determined for a catheter-based procedure according to the Heart team’s
decision. Informed consent was obtained from all patients.